Open: 0.0 Close: 0.0 Change: 0.0

Today's Summary

Surmodics will report an earnings per share (EPS) of $-0.20. analysts estimate that the company will report a price change. investors are eagerly awaiting the companys announcement.Surmodics has a consensus rating of Buy. Company Consensus Revenue Growth Gross Profit Return on Equity Buy -2.06% $13.56M -3.17% Treace Medical Concepts Neutral 10.44% $55.48M. ClearPoint Neuro Buy 14.11% $4.76M -19.81% Delcath Systems Buy 2701.48% $12.97M -8.79% Key Takeaway: Surmodicas ranks at the